manilatimes15h
aTyr Pharma to Present Three Posters for Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference
Current epidemiology and treatment practices for pulmonary sarcoidosis in the U.S. based on real-world evidence ...
Le Lézard21h
The FDA Grants Vicore's Buloxibutid Fast Track Designation for Idiopathic Pulmonary Fibrosis
STOCKHOLM, SE / ACCESS Newswire / January 29, 2025 / Vicore Pharma Holding (STO:VICO)Stockholm, January 29, 2025 - Vicore Pharma Holding AB (STO: VICO), unlocking the potential of a novel class of ...